| Patents for C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637) |
|---|
| 12/27/2007 | WO2007086883A3 Cationic lipids and formulated molecular compositions containing them |
| 12/27/2007 | US20070298456 Microbiological process for the production of 7-substitued 11-hydroxy steroids, 7,17-substituted 11-halogen steroids, and uses thereof |
| 12/26/2007 | CN100357311C 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 12/25/2007 | US7312206 Sterol derivatives, liposomes comprising sterol derivatives and method for loading liposomes with active substances |
| 12/21/2007 | WO2007144674A1 INDUSTRIAL PROCESS FOR THE SYNTHESIS OF 17α-ACETOXY-11β-[4-(N,N-DIMETHYL-AMINO)- PHENYL]-19-NORPREGNA-4,9-DIENE-3,20-DIONE AND NEW INTERMEDIATES OF THE PROCESS |
| 12/21/2007 | CA2653552A1 Industrial process for the synthesis of 17.alpha.-acetoxy-11.beta.-[4-(n,n-dimethyl-amino)-phenyl]-19-norpregna-4,9-diene-3,20-dione and new intermediates of the process |
| 12/20/2007 | US20070292967 Assay for Ligands of the Ecdysone Receptor |
| 12/20/2007 | DE19943708B4 Neue C13-substituierte Estra-1,3,5(10)-trien-3-yl-sulfamate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen New C13-substituted estra-1,3,5 (10) -triene-3-yl-sulfamate, to their preparation and to pharmaceutical compositions containing these compounds, method |
| 12/19/2007 | CN100355771C Process for the synthesis of high purity D-(17alpha)-13-ethyl-17 -hydroxy-18,19-dinorpre:gn-4-ene-20-yne-3-one-oxime |
| 12/13/2007 | WO2007095174A3 Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions |
| 12/12/2007 | CN100354300C Method of obtaining 17alpha-acetoxy-11beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione |
| 12/05/2007 | EP1862469A2 New solid forms of mesoprogestin 11Beta-[4E-(hydroxyimino methyl)-phenyl]-17alpha-methoxymethyl-17beta-methoxy-estra-4,9-dien-3-on |
| 12/04/2007 | US7304171 Compounds and methods for cytoprotection |
| 11/29/2007 | US20070275935 Estratriene Derivatives |
| 11/21/2007 | CN101076538A Steroids for cancer treatment |
| 11/14/2007 | CN100348609C Glucocorticoid receptor ligands for the treatment of metabolic disorders |
| 11/13/2007 | CA2480004C Process for production of steroid crystals, crystals obtained thereby and their use in pharmaceutical preparations |
| 11/08/2007 | WO2007062877A3 PRODRUG ERβ-SELECTIVE SUBSTANCES, METHODS FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS |
| 11/07/2007 | CN100347186C Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation |
| 11/06/2007 | US7291610 Estrogenic compounds as anti-mitotic agents |
| 10/31/2007 | CN101065395A Process for the preparation of 3-oximino steroids |
| 10/30/2007 | CA2382106C Steroids, their preparation, pharmaceutical compositions thereof and uses of the compounds |
| 10/25/2007 | WO2007118832A2 Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
| 10/25/2007 | WO2007118717A2 METHOD FOR PREPARING 4-[17β-METHOXY-17α-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11β-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL) |
| 10/25/2007 | DE102006018888A1 Verfahren zur Herstellung von 4-[17beta-Methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl]benzaldehyd-(E)-oxims (Asoprisnil) Process for the preparation of 4- [17beta-methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl] benzaldehyde (E) -oxime (asoprisnil) |
| 10/25/2007 | CA2839228A1 Method for preparing 4-[17.beta.-methoxy-17.alpha.-methoxymethyl-3-oxoestra-4,9-dien-11.beta.-yl]benzaldehyde (e)-oxime (asoprisnil) |
| 10/25/2007 | CA2649175A1 Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
| 10/25/2007 | CA2648537A1 Method for preparing 4-[17.beta.-methoxy-17.alpha.-methoxymethyl-3-oxoestra-4,9-dien-11.beta.-yl]benzaldehyde (e)-oxime (asoprisnil) |
| 10/24/2007 | EP1847548A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 10/24/2007 | EP1846435A1 Tetracyclic terpene series compounds, methods for preparing same, uses thereof as medicines and pharmaceutical compounds containing same |
| 10/23/2007 | CA2478971C Androstenones |
| 10/23/2007 | CA2449679C Androstenones |
| 10/23/2007 | CA2280041C Antigestagenic steroids with a fluorinated 17.alpha.-alkyl chain |
| 10/17/2007 | EP1392713B1 Liver x receptor agonists |
| 10/17/2007 | CN100343272C Antitumoral d-homoestra-1, 3, 5 (10)-trien-3-yl 2-substituted sulfamates |
| 10/10/2007 | EP1841780A2 Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions |
| 10/10/2007 | EP1105407B1 Aminosterol compounds and uses thereof |
| 10/04/2007 | US20070232570 11-phosphorous steroid derivatives useful as progesterone receptor modulators |
| 10/04/2007 | CA2681639A1 Compounds and methods for treatment of disorders associated with er stress |
| 09/27/2007 | WO2007062874B1 Sulfamoyl sulfonate prodrugs |
| 09/27/2007 | US20070225256 Compound |
| 09/26/2007 | EP1836215A1 Androstane 17-alpha-carbonate for use in the treatment of inflammatory and allergic conditions |
| 09/26/2007 | CN100339486C Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 09/20/2007 | WO2007080270A3 New cholest-4-en-3-one oxime derivatives, pharmaceutical compositions comprising them, and preparation process |
| 09/18/2007 | CA2236648C Sulfatation of estrogen mixtures |
| 09/13/2007 | WO2007022089A3 Methods to identify therapeutic agents useful for treating and preventing atherosclerosis by counteracting the effect of cholesterol ozonation products |
| 09/12/2007 | EP1832598A2 Therapeutic treatment of androgen receptor driven conditions |
| 09/11/2007 | US7268241 Therapy for hormone sensitive diseases; contraceptives |
| 08/30/2007 | WO2007008474A3 3 -ester prodrugs of estradiol |
| 08/28/2007 | US7262023 synthesis of steroids by hydroxylation and oxidation with use of microoganisms; biosynthesis |
| 08/23/2007 | US20070197484 Method of treating disorder related to high cholesterol concentration |
| 08/23/2007 | CA2642220A1 Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions |
| 08/22/2007 | CN1332974C Nevol anti-estrogenic steroids, and associated pharmaceutical compositions and method of use |
| 08/15/2007 | EP1818338A1 Process for the preparation of norelgestromin |
| 08/15/2007 | EP1817325A2 Sulfated molecular umbrellas containing 6-200 cholanic acid (derivative) units as anti-hiv and anti-hsv agents |
| 08/14/2007 | CA2421302C 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 08/09/2007 | WO2007066158A3 HIGH PURITY 17α-CYANOMETHYL-17β-HYDROXY-ESTRA-4,9-DIENE-3-ONE AND PROCESS FOR THE SYNTHESIS THEREOF |
| 08/09/2007 | WO2007024338A3 3 -ester prodrugs of ethynylestradiol |
| 08/09/2007 | WO2006072600A8 Androstane 17-alpha-carbonate for use in the treatment of inflammatory and allergic conditions |
| 08/02/2007 | CA2597724A1 Cationic lipids and formulated molecular compositions containing them |
| 07/31/2007 | CA2223397C Novel nor-pregnanes for inducing hypothalamic effects |
| 07/26/2007 | WO2007025780A3 Aldosterone receptor antagonists |
| 07/19/2007 | WO2007080951A1 Process for production of steroids |
| 07/19/2007 | WO2007080270A2 New cholest-4-en-3-one oxime derivatives, pharmaceutical compositions comprising them, and preparation process |
| 07/19/2007 | WO2007016656A8 Modulators of hypoxia inducible factor-1 and related uses for the treatment of ocular disorders |
| 07/19/2007 | CA2633633A1 New cholest-4-en-3-one oxime derivatives, pharmaceutical compositions comprising them, and preparation process |
| 07/17/2007 | US7244762 Antitumoral d-homoestra-1,3,5 (10)-trien-3-yl 2-substituted sulfamates |
| 07/17/2007 | CA2158610C 17-deoxycorticosteroid-21-/o/-carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 07/12/2007 | WO2007062874A3 Sulfamoyl sulfonate prodrugs |
| 07/12/2007 | US20070161612 angiogenesis inhibitor; antiinflammatory agents; immunosuppressants; steroids conjugated compound |
| 07/11/2007 | EP1806354A2 Amphoteric sterols and their use |
| 07/11/2007 | EP1806350A2 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents |
| 07/11/2007 | CN1325507C 17alpha-alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations |
| 07/05/2007 | US20070154447 Linear polyethylenimine-sterol conjugates for gene delivery |
| 07/04/2007 | CN1993375A Steroid prodrugs with androgenic effect. |
| 07/03/2007 | CA2133607C Corticoid -17,21-dicarboxylic esters and corticosteroid 17-caboxylic esters 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 07/03/2007 | CA2130943C Corticosteroid 17-alkyl carbonate 21-[o]-carboxylic and carbonic esters, processes for their preparation, and pharmaceuticals containing these compounds |
| 06/27/2007 | EP1272459B1 7- and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds |
| 06/26/2007 | US7235678 Bile acid derived steroidal dimers with novel amphiphilic topology having antifungal activity |
| 06/26/2007 | US7235675 Conjugates of mycophenolic acid |
| 06/26/2007 | US7235552 Cholenic acid amides and pharmaceutical compositions thereof |
| 06/21/2007 | US20070142631 Enzyme inhibiton immunoassay |
| 06/21/2007 | US20070142345 Steroids for cancer treatment |
| 06/21/2007 | US20070142342 Pharmaceutical compounds |
| 06/21/2007 | US20070142340 Steroids as agonists for FXR |
| 06/20/2007 | EP1379254B1 Use of bile acid or bile salt fatty acid conjugates |
| 06/20/2007 | EP1105408B1 Congugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 06/19/2007 | CA2281844C Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 06/14/2007 | WO2007066158A2 HIGH PURITY 17α-CYANOMETHYL-17β-HYDROXY-ESTRA-4,9-DIENE-3-ONE AND PROCESS FOR THE SYNTHESIS THEREOF |
| 06/14/2007 | WO2007065726A1 11β-BENZALDOXIME DERIVATIVES OF D-HOMOOESTRA-4,9-DIEN-3-ONES |
| 06/14/2007 | US20070135400 Estradiol derivatives |
| 06/14/2007 | CA2631748A1 High purity 17.alpha.-cyanomethyl-17.beta.-hydroxy-estra-4,9-diene-3-one and process for the synthesis thereof |
| 06/14/2007 | CA2631364A1 11.beta.-benzaldoxime derivatives of d-homooestra-4,9-dien-3-ones |
| 06/13/2007 | EP1794176A2 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 06/13/2007 | EP1363932B1 Amphoteric sterols and the use thereof |
| 06/07/2007 | WO2007063930A1 Method for producing vitamin d derivative utilizing photoreaction |
| 06/07/2007 | WO2007062876A1 Prodrugs of er-beta-selective substances method for production thereof and pharmaceutical compositions comprising the same |
| 06/07/2007 | WO2007062874A2 Sulfamoyl sulfonate prodrugs |
| 06/07/2007 | WO2007016656A3 Modulators of hypoxia inducible factor-1 and related uses for the treatment of ocular disorders |
| 06/07/2007 | CA2632272A1 Sulfamoyl sulfonate prodrugs |